Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment‐experienced and/or have multidrug‐resistant HIV‐1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy

Ähnliche Einträge

• Intracellular dried blood spot metabolite concentrations for assessing antiretroviral adherence and HIV progression
  von: Julie B. Dumond
  Veröffentlicht: (2025)
• Consensus recommendations for use of long‐acting antiretroviral medications in the treatment and prevention of HIV‐1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy, Canadian HIV and Viral Hepatitis Pharmacists Network, European AIDS Clinical Society, and Society of Infectious Diseases Pharmacists
  von: Elizabeth M. Sherman, et al.
  Veröffentlicht: (2024)
• Influence of hospital admission in the pharmacotherapy complexity of HIV+ patients
  von: María de las Aguas Robustillo Cortés
  Veröffentlicht: (2017)
• Correction to “International consensus recommendations for the use of prolonged‐infusion beta‐lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists”
  Veröffentlicht: (2024)
• Changes in serum potassium in people with type 2 diabetes taking sodium‐glucose co‐transporter‐2 inhibitors
  von: Kellye Eagan, et al.
  Veröffentlicht: (2025)